Impact of Δ32-CCR5 heterozygosity on HIV-1 genetic evolution and variability-A study of 4 individuals infected with closely related HIV-1 strains

Virology

Volumn 379, Issue 2, 2008, Pages 213-222

  Chalmet, Kristen ^a   Van Wanzeele, Filip ^b   Demecheleer, Els ^a   Dauwe, Kenny ^a   Pelgrom, Jolanda ^b   Van Der Gucht, Bea ^b   Vogelaers, Dirk ^b   Plum, Jean ^a   Stuyver, Lieven ^c   Vandekerckhove, Linos ^b   Verhofstede, Chris ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c Virco BVBA   (Belgium)

Author keywords

32 CCR5 heterozygosity; HIV 1 evolution

Indexed keywords

ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; GENE DELETION; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR GENE; VIRUS REPLICATION; VIRUS STRAIN;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BASE SEQUENCE; DNA PRIMERS; EVOLUTION, MOLECULAR; GENES, ENV; GENOTYPE; HETEROZYGOTE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; RECEPTORS, CCR5; RNA, VIRAL; SEQUENCE DELETION; VARIATION (GENETICS);

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 50649104801     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.06.036     Document Type: Article

References (32)

1. Ball S.C., Abraha A., Collins K.R., Marozsan A.J., Baird H., Quinones-Mateu M.E., Penn-Nicholson A., Murray M., Richard N., Lobritz M., Zimmerman P.A., Kawamura T., Blauvelt A., and Arts E.J. Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C. J. Virol. 77 2 (2003) 1021-1038
2. Carmichael A., Jin X., and Sissons P. Analysis of the human env-specific cytotoxic T-lymphocyte (CTL) response in natural human immunodeficiency virus type 1 infection: low prevalence of broadly cross-reactive env-specific CTL. J. Virol. 70 12 (1996) 8468-8476
3. Deacon N.J., Tsykin A., Solomon A., Smith K., Ludfordmenting M., Hooker D.J., Mcphee D.A., Greenway A.L., Ellett A., Chatfield C., Lawson V.A., Crowe S., Maerz A., Sonza S., Learmont J., Sullivan J.S., Cunningham A., Dwyer D., Dowton D., and Mills J. Genomic structure of an attenuated quasi-species of HIV-1 from a blood-transfusion donor and recipients. Science 270 5238 (1995) 988-991
4. Draenert R., Allen T.M., Liu Y., Wrin T., Chappey C., Verrill C.L., Sirera G., Eldridge R.L., Lahaie M.P., Ruiz L., Clotet B., Petropoulos C.J., Walker B.D., and Martinez-Picado J. Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus. J. Exp. Med. 203 3 (2006) 529-539
5. Essajee S.M., Kim M., Gonzalez C., Rigaud M., Kaul A., Chandwani S., Hoover W., Lawrence R., Spiegel H., Pollack H., Krasinski K., and Borkowsky W. Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children. Aids 13 18 (1999) 2523-2532
6. Ganeshan S., Dickover R.E., Korber B.T.M., Bryson Y.J., and Wolinsky S.M. Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease. J. Virol. 71 1 (1997) 663-677
7. Goulder P.J.R., and Watkins D.I. HIV and SIVCTL escape: implications for vaccine design. Nat. Rev. Immunol. 4 8 (2004) 630-640
8. Gunthard H.F., Frost S.D.W., Leigh-Brown A.J., Ignacio C.C., Kee K., Perelson A.S., Spina C.A., Havlir D.V., Hezareh M., Looney D.J., Richman D.D., and Wong J.K. Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy. J. Virol. 73 11 (1999) 9404-9412
9. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 98/98/NT. Nucl. Acids Symp. Ser. 41 (1999) 95-98
10. Husman A.M.D., Koot M., Cornelissen M., Keet I.P.M., Brouwer M., Broersen S.M., Bakker M., Roos M.T.L., Prins M., deWolf F., Coutinho R.A., Miedema F., Goudsmit J., and Schuitemaker H. Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann. Intern. Med. 127 10 (1997) 882
11. Hutto C., Zhou Y., He J., Geffin R., Hill M., Scott W., and Wood C. Longitudinal studies of viral sequence, viral phenotype, and immunologic parameters of human immunodeficiency virus type 1 infection in perinatally infected twins with discordant disease courses. J. Virol. 70 6 (1996) 3589-3598
12. Ioannidis J.P.A., Rosenberg P.S., Goedert J.J., Ashton L.J., Benfield T.L., Buchbinder S.P., Coutinho R.A., Eugen-Olsen J., Gallart T., Katzenstein T.L., Kostrikis L.G., Kuipers H., Louie L.G., Mallal S.A., Margolick J.B., Martinez O.P., Meyer L., Michael N.L., Operskalski E., Pantaleo G., Rizzardi G.P., Schuitemaker H., Sheppard H.W., Stewart G.J., Theodorou I.D., Ullum H., Vicenzi E., Vlahov D., Wilkinson D., Workman C., Zagury J.F., O'Brien T.R., and Genetics I.M.A.H.H. Effects of CCR5-Delta 32, CCR2-641, and SDF-1 3' A alleles on HIV-1 disease progression: an international meta-analysis of individual-patient data. Ann. Intern. Med. 135 9 (2001) 782-795
13. Jensen M.A., Li F.S., van't Wout A.B., Nickle D.C., Shriner D., He H.X., McLaughlin S., Shankarappa R., Margolick J.B., and Mullins J.I. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J. Virol. 77 24 (2003) 13376-13388
14. Kirchhoff F., Greenough T.C., Brettler D.B., Sullivan J.L., and Desrosiers R.C. Brief report - absence of intact Nef sequences in a long-term survivor with nonprogressive Hiv-1 infection. N. Engl. J. Med. 332 4 (1995) 228-232
15. Liu S.L., Schacker T., Musey L., Shriner D., McElrath M.J., Corey L., and Mullins J.I. Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses. J. Virol. 71 6 (1997) 4284-4295
16. Lukashov V.V., Kuiken C.L., and Goudsmit J. Intrahost human-immunodeficiency-virus Type-1 evolution is related to length of the immunocompetent period. J. Virol. 69 11 (1995) 6911-6916
17. Mani I., Gilbert P., Sankale J.L., Eisen G., Mboup S., and Kanki P.J. Intrapatient diversity and its correlation with viral setpoint in human immunodeficiency virus type 1 CRF02_A/G-IbNG infection. J. Virol. 76 21 (2002) 10745-10755
18. Markham R.B., Wang W.C., Weisstein A.E., Wang Z., Munoz A., Templeton A., Margolick J., Vlahov D., Quinn T., Farzadegan H., and Yu X.F. Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline. Proc. Natl. Acad. Sci. U. S. A. 95 21 (1998) 12568-12573
19. Marozsan A.J., Torre V.S., Johnson M., Ball S.C., Cross J.V., Templeton D.J., Quinones-Mateu M.E., Offord R.E., and Arts E.J. Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES. J. Virol. 75 18 (2001) 8624-8638
20. Mikhail M., Wang B., Lemey P., Beckholdt B., Vandamme A.M., Gill M.J., and Saksena N.K. Full-length HIV type 1 genome analysis showing evidence for HIV type 1 transmission from a nonprogressor to two recipients who progressed to AIDS. AIDS Res. Hum. Retrovir. 21 6 (2005) 575-579
21. Page R.D.M. TreeView: an application to display phylogenetic trees on personal computers. Comput. Appl. Biosci. 12 4 (1996) 357-358
22. Parren P.W.H.I., Moore J.P., Burton D.R., and Sattentau Q.J. The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity. Aids 13 (1999) S137-S162
23. Posada D., and Crandall K.A. MODELTEST: testing the model of DNA substitution. Bioinformatics 14 9 (1998) 817-818
24. Rangel H.R., Weber J., Chakraborty B., Gutierrez A., Marotta M.L., Mirza M., Kiser P., Martinez M.A., Este J.A., and Quinones-Mateu M.E. Role of the human immunodeficiency virus type 1 envelope gene in viral fitness. J. Virol. 77 16 (2003) 9069-9073
25. Rosenberg E.S., Altfeld M., Poon S.H., Phillips M.N., Wilkes B.M., Eldridge R.L., Robbins G.K., D'Aquila R.T., Goulder P.J.R., and Walker B.D. Immune control of HIV-1 after early treatment of acute infection. Nature 407 6803 (2000) 523-526
26. Shankarappa R., Margolick J.B., Gange S.J., Rodrigo A.G., Upchurch D., Farzadegan H., Gupta P., Rinaldo C.R., Learn G.H., He X., Huang X.L., and Mullins J.I. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73 12 (1999) 10489-10502
27. Strunnikova N., Ray S.C., Livingston R.A., Rubalcaba E., and Viscidi R.P. Convergent evolution within the V3 loop domain of human-immunodeficiency-virus type-1 in association with disease progression. J. Virol. 69 12 (1995) 7548-7558
28. Sutthent R., Foongladda S., Chearskul S., Wanprapa N., Likanonskul S., Kositanont U., Riengrojpitak S., Sahaphong S., and Wasi C. V3 sequence diversity of HIV-1 subtype E in infected mothers and their infants. J. Acquir. Immune Defic. Syndr. 18 4 (1998) 323-331
29. Thompson J.D., Higgins D.G., and Gibson T.J. Improved sensitivity of profile searches through the use of sequence weights and gap excision. Comput. Appl. Biosci. 10 1 (1994) 19-29
30. Troyer R.M., Collins K.R., Abraha A., Fraundorf E., Moore D.M., Krizan R.W., Toossi Z., Colebunders R.L., Jensen M.A., Mullins J.I., Vanham G., and Arts E.J. Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression. J. Virol. 79 14 (2005) 9006-9018
31. Wolinsky S.M., Korber B.T.M., Neumann A.U., Daniels M., Kunstman K.J., Whetsell A.J., Furtado M.R., Cao Y.Z., Ho D.D., Safrit J.T., and Koup R.A. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272 5261 (1996) 537-542
32. Zhu T.F., Mo H.M., Wang N., Nam D.S., Cao Y.Z., Koup R.A., and Ho D.D. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261 5125 (1993) 1179-1181